KOENIG SHELDON L. (Chief Operating Officer) received a stock award from ESPERION THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/16/2026ACC: 0001628280-26-018192
Officer· Chief Operating Officer
Since Dec 2020
+1.37M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
1.37M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+723.76K
Price / share
—
Trade value
—
% of position
49.1%
3/13/2026
1.47M→2.20M
Total
Net shares
+723.76K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/13/2026 | A · Award | +723.76K | — | — | 49.1% | 1.47M | 2.20M |
| Total | +723.76K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
647.46K shares
Shares
+647.46K
Strike price
2.44
Held after
647.46K
Exercisable
—
3/13/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock647.46K shares | 3/13/2026 | A · Award | +647.46K | 2.44 | — | 647.46K |